Ata Gnrh Testing Against

---
name: ata-gnrh-testing-against
description: Recommends against performing dynamic GnRH stimulation testing in the evaluation of hypogonadism, as it provides no additional diagnostic information beyond baseline gonadotropins and sex steroids. Consider this recommendation when evaluating hypogonadism and contemplating GnRH testing.
---

# Recommend against dynamic testing with GnRH for hypogonadism evaluation

## STEP 1 — Gather Information
Collect symptoms of hypogonadism (e.g., low libido, fatigue, menstrual irregularities) and baseline labs: serum testosterone (or estradiol in females), LH, FSH, prolactin. Record these values and clinical context.

## STEP 2 — Rule In / Rule Out
If symptoms and baseline labs do not suggest hypogonadism (normal sex steroids with appropriate gonadotropins), stop evaluation; otherwise proceed to classify the type of hypogonadism.

## STEP 3 — Classify or Stratify
Classify as central hypogonadism when testosterone/estradiol is low with low or inappropriately normal LH/FSH; classify as primary hypogonadism when sex steroids are low with elevated LH/FSH.

## STEP 4 — Decide
Do not order GnRH dynamic testing; manage based on classification (e.g., consider testosterone replacement for central hypogonadism after excluding hyperprolactinemia, thyroid disease, and other causes).

## Clinical Guardrails / Mimics / Pitfalls
- Avoid GnRH testing; it adds no diagnostic value and increases cost and patient burden.
- Do not mistake low LH/FSH with normal testosterone for central hypogonadism without confirming symptoms and excluding exogenous hormone effects.
- Remember that hyperprolactinemia, thyroid dysfunction, and chronic illness can mimic hypogonadism; check prolactin and TSH before attributing low sex steroids to pituitary failure.
- Never initiate testosterone replacement solely on low testosterone without assessing LH/FSH to differentiate central vs primary etiology.

## Concrete Clinical Example
A 45‑year‑old man reports decreased libido and erectile dysfunction. Baseline testosterone is 220 ng/dL (low), LH 1.2 IU/L (low‑normal), FSH 1.5 IU/L (low‑normal), prolactin normal. Instead of ordering a GnRH test, the clinician classifies this as central hypogonadism, orders a pituitary MRI, and after ruling out other causes, initiates testosterone replacement.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118